The massive warrant coverage (100% of shares sold) creates substantial overhang that will likely pressure the stock until the registration statement is filed and warrants become exercisable in 6 months. Monitor for any early exercise or cashless exercise activity that could accelerate dilution.
Price Chart
Executive Summary
Curis entered into a securities purchase agreement to sell an aggregate of $8,500,006.80 of shares (or pre-funded warrants in lieu thereof) and common warrants in a registered direct offering priced at $0.51 per share. The offering includes common warrants exercisable at $0.60 per share for 100% of the share count, representing significant potential dilution of approximately 406% of current shares outstanding. Net proceeds will be used for research, development, working capital, and general corporate purposes.
Key Financial Metrics
Key Facts
- Aggregate offering size of $8,500,006.80
- Per Share Purchase Price of $0.51
- Common Warrants to purchase 16,666,680 shares at $0.60 per share (100% warrant coverage)
- Pre-Funded Warrants available at $0.50 per share with $0.01 exercise price
- As of September 30, 2026, there were 4,104,712 shares of Common Stock outstanding
- Common Warrants exercisable 6 months after issuance through April 19, 2032
- Registration Rights Agreement requires filing of resale registration statement within 30 days of closing
- Lock-up agreements with directors and executive officers
- Use of proceeds: research, development, working capital, and other general corporate purposes
- Placement Agents: A.G.P./Alliance Global Partners and Laidlaw & Company (UK) Ltd.
Financial Impact
Dilution of approximately 406% based on 4,104,712 shares outstanding as of September 30, 2026, with 16,666,680 warrant shares potentially issuable upon exercise of common warrants at $0.60 per share, plus additional shares from pre-funded warrants
Risk Factors
- Extreme dilution of ~406% from warrant shares alone, not including pre-funded warrants
- Warrant exercise price of $0.60 is only ~18% above the $0.51 purchase price, providing limited upside buffer
- Registration rights may lead to rapid resale of shares once effective
- Cashless exercise provision could accelerate dilution if registration statement is not effective
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001104659-26-116910 |
| Document: tm2627615d1_ex10-2.htm | 0001104659-26-116910 |
| Document: tm2627615d1_ex4-1.htm | 0001104659-26-116910 |
| Document: tm2627615d1_ex4-2.htm | 0001104659-26-116910 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 19, 2026 7d ago | 8-K | $0.3996 | awaiting T+20 | — | $0.3800 (+4.90%) |
Oct 16, 2026 10d ago | Press Release | $0.4071 | awaiting T+20 | — | $0.3800 (+6.66%) |
Aug 13, 2026 10w ago | EFFECT | $1.87 $1.13 | ▲ +39.57% | ▲ +37.83% | $0.3800 (+79.68%) |
Jul 30, 2026 12w ago | 8-K | $5.02 $1.49 | ▼ −70.32% | ▼ −73.31% | $0.3800 (−92.43%) |
Jul 2, 2026 16w ago | 8-K | $0.3466 $4.96 | ▲ +1331.04% | ▲ +1331.46% | $0.3800 (+9.64%) |
May 22, 2026 22w ago | 8-K | $9.80 $6.80 | ▲ +30.61% | ▲ +28.55% | $0.3800 (+96.12%) |
May 12, 2026 23w ago | 8-K | $10.00 $8.60 | ▲ +14.00% | ▲ +13.39% | $0.3800 (+96.20%) |
May 1, 2026 25w ago | 8-K | $11.60 $10.00 | ▲ +13.79% | ▲ +19.58% | $0.3800 (+96.72%) |
Mar 23, 2026 31w ago | EFFECT | $0.7400 $0.6000 | ▼ −18.92% | ▼ −26.34% | $0.3800 (−48.65%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers